Stay updated with breaking news from Colitis Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.10.2023 - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely ...
Three teenagers are the brains and hands behind a new app that could make life easier for the millions of Americans living with inflammatory bowel diseases.
Three teenagers are the brains and hands behind a new app that could make life easier for the millions of Americans living with inflammatory bowel diseases.
Three teenagers are the brains and hands behind a new app that could make life easier for the millions of Americans living with inflammatory bowel diseases.
If the Crohn’s & Colitis Foundation has anything to say about it, a cure for Crohn’s, Ulcerative Colitis, and many other conditions could be right around the corner.